Your session is about to expire
← Back to Search
Pilot Intervention for Type 1 Diabetes (BEAD-T1D Trial)
N/A
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of one year
Awards & highlights
BEAD-T1D Trial Summary
This trial aims to study and improve diabetes care for young people from low-income backgrounds. The research will focus on understanding the barriers and promoters of diabetes management in publicly insured youth and work towards reducing disparities in
Who is the study for?
This trial is for young people aged 12-21 with Type 1 Diabetes, especially from low socioeconomic backgrounds. Participants must be living with a parent or guardian if under 18 (with their consent) and can give personal consent if over 18.Check my eligibility
What is being tested?
The BEAD-T1D study aims to increase the use of diabetes technology among disadvantaged youths. It will explore barriers to care, aiming to improve diabetes management and outcomes in this group.See study design
What are the potential side effects?
Since this intervention focuses on increasing access to diabetes technology rather than a drug or medical procedure, traditional side effects are not applicable. However, there may be psychological or social impacts from participating in the study.
BEAD-T1D Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Interviews with you on your feedback on the intervention
Survey questions on your feedback on the intervention
Tracking people who complete the study
Secondary outcome measures
Changes in diabetes technology usage
BEAD-T1D Trial Design
1Treatment groups
Experimental Treatment
Group I: Pilot InterventionExperimental Treatment1 Intervention
The design for this phase is a prospective pilot study. The intervention modules (co-developed with the stakeholder advisory board in Phase 1 of this aim) will be delivered weekly over a four-week period and will include pre- and post-intervention assessments of survey measurements. The investigators will also evaluate youth diabetes management and technology use. Families will be compensated in a stepwise fashion. Virtual delivery of the pilot intervention will facilitate national recruitment and allow for recruitment during the pandemic or any ensuing limitations to in-person recruitment.
Find a Location
Who is running the clinical trial?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,364 Previous Clinical Trials
4,315,315 Total Patients Enrolled
Stanford UniversityLead Sponsor
2,396 Previous Clinical Trials
17,341,535 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities for individuals to enroll in this ongoing study?
"Indeed, information from clinicaltrials.gov indicates that this trial is presently seeking individuals to participate. The trial was initially listed on June 15th, 2023 and last revised on April 15th, 2024. Researchers are aiming to enroll a total of 20 patients at a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger